Nasal continuous positive airway pressure (NCPAP) or noninvasive neurally adjusted ventilatory assist (NIV-NAVA) for preterm infants with respiratory distress after birth: A randomized controlled trial

Pediatric Pulmonology
Ana C YaguiCelso M Rebello

Abstract

To compare rates of treatment failure between the use of nasal continuous positive airway pressure (NCPAP) and noninvasive neurally adjusted ventilatory assist (NIV-NAVA) in infants with respiratory distress after birth. A randomized, unblinded, double-center trial was conducted in infants with birth weights (BWs) less than or equal to 1500 g and respiratory distress receiving noninvasive respiratory support for less than or equal to 48 hours of life; some infants were initially treated with minimally invasive surfactant therapy as the standard of care. need for endotracheal intubation with use of mechanical ventilation (MV) at less than or equal to 72 hours of life using prespecified failure criteria. use of surfactant, duration of noninvasive support, duration of MV, bronchopulmonary dysplasia (BPD) and death. A total of 123 infants were included (NCPAP group = 64 and NIV-NAVA group = 59). Population characteristics were similar between groups. No difference in the primary outcome was observed: NCPAP = 10 (15.6%) and NIV-NAVA = 12 (20.3%), P = .65. Groups were also similar in the use of surfactant (19 vs 17), duration of noninvasive support (147 ± 181 hours vs 127 ± 137 hours), BPD incidence and death. However, duration of MV...Continue Reading

References

Sep 27, 2005·The Journal of Pediatrics·Amer AmmariRichard A Polin
Aug 23, 2007·Archives of Disease in Childhood. Fetal and Neonatal Edition·Louise S OwenPeter G Davis
Mar 12, 2008·Current Opinion in Pediatrics·Colin J Morley, Peter G Davis
Aug 5, 2009·Pediatrics·Vineet BhandariUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Oct 23, 2009·Journal of Perinatology : Official Journal of the California Perinatal Association·V Bhandari
May 22, 2010·Archives of Disease in Childhood. Fetal and Neonatal Edition·L S OwenP G Davis
Feb 22, 2011·Archives of Disease in Childhood. Fetal and Neonatal Edition·L S OwenP G Davis
Dec 6, 2011·The Journal of Pediatrics·Howard Stein, Diane Howard
Sep 8, 2012·Clinics in Perinatology·Howard SteinPeter C Rimensberger
Sep 11, 2012·Archives of Disease in Childhood. Fetal and Neonatal Edition·Eduardo Bancalari, Nelson Claure
Aug 16, 2013·The New England Journal of Medicine·Haresh KirpalaniUNKNOWN NIPPV Study Group
Jun 20, 2014·Archives of Disease in Childhood. Fetal and Neonatal Edition·L S OwenP G Davis
Sep 5, 2014·Journal of Perinatology : Official Journal of the California Perinatal Association·T TagliaferroR A Polin
Jun 5, 2015·Journal of Perinatology : Official Journal of the California Perinatal Association·A Mukerji, J Belik
Jul 17, 2015·Archives of Disease in Childhood. Fetal and Neonatal Edition·Juyoung LeeJung-Hwan Choi
Feb 24, 2016·Seminars in Fetal & Neonatal Medicine·Howard SteinMichael Dunn
Mar 5, 2016·Seminars in Fetal & Neonatal Medicine·Rakesh SahniRichard A Polin
Nov 14, 2016·Clinics in Perinatology·Kimberly S FirestoneHoward Stein
Jul 25, 2018·JAMA Pediatrics·Christopher P Bonafide, Ron Keren

❮ Previous
Next ❯

Citations

May 1, 2020·Pediatric Pulmonology·Richard L Auten
Apr 10, 2020·Archives of Disease in Childhood. Fetal and Neonatal Edition·Marie-Eve RochonGuillaume Emeriaud
Mar 17, 2021·International Journal of Immunopathology and Pharmacology·Mohamed Shawky ElfarargyHaidy Khattab

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.